{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:14:19Z","timestamp":1791404059258,"version":"4.3.3"},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.4158\/ep10390.cr","type":"journal-article","created":{"date-parts":[[2011,3,31]],"date-time":"2011-03-31T22:18:43Z","timestamp":1301609923000},"page":"e59-e62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Mebendazole Monotherapy and Long-Term Disease Control in Metastatic Adrenocortical Carcinoma"],"prefix":"10.1016","volume":"17","author":[{"given":"Irina Y.","family":"Dobrosotskaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary D.","family":"Hammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Schteingart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Maturen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis P.","family":"Worden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP10390.CR_bb0010","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1677\/erc.1.01029","article-title":"Management of patients with adrenal cancer: Recommendations of an international consensus conference","volume":"12","author":"Schteingart","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"10.4158\/EP10390.CR_bb0015","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Endocrine Society. Case detection, diagnosis, and treatment of patients with primary aldosteronism: An endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP10390.CR_bb0020","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: An Endocrine Society Clinical Practice Guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP10390.CR_bb0025","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0035-9203(71)90061-7","article-title":"Mebendazole (R-17,635): A new anthelmintic in the development of hookworms","volume":"65","author":"Banerjee","year":"1971","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.4158\/EP10390.CR_bb0030","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0169-4758(90)90227-U","article-title":"Mode of action of benzimidazoles","volume":"6","author":"Lacey","year":"1990","journal-title":"Parasitol Today"},{"key":"10.4158\/EP10390.CR_bb0035","first-page":"586","article-title":"Synthesis and anthelminthic activity of alkyl-(5-acyl-1-H-benzimidazol-2-yl) carbamates","volume":"28","author":"Raeymaekers","year":"1978","journal-title":"Arzneimittelforschung"},{"key":"10.4158\/EP10390.CR_bb0040","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/(SICI)1098-1128(199603)16:2<207::AID-MED4>3.0.CO;2-4","article-title":"Antimitotic natural products and their interactions with tubulin","volume":"16","author":"Hamel","year":"1996","journal-title":"Med Res Rev"},{"key":"10.4158\/EP10390.CR_bb0045","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.cellbio.16.1.89","article-title":"Structural basis for the interaction of tubulin with proteins and drugs that affect microtubule dynamics","volume":"16","author":"Downing","year":"2000","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.4158\/EP10390.CR_bb0050","first-page":"2963","article-title":"Mebendazole elicits a potent antitumor effect on human cancer cell lines both in vitro and in vivo","volume":"8","author":"Mukhopadhyay","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.4158\/EP10390.CR_bb0055","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00280-007-0538-0","article-title":"Mebendazole inhibits growth of human adrenocortical carcinoma cell lines implanted in nude mice","volume":"61","author":"Martarelli","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.4158\/EP10390.CR_bb0060","first-page":"1201","article-title":"The anthelmintic drug mebendazole induces mitotic arrest and apoptosis by depolymerizing tubulin in non-small cell lung cancer cells","volume":"1","author":"Sasaki","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"10.4158\/EP10390.CR_bb0065","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1158\/1541-7786.MCR-07-2159","article-title":"Mebendazole induces apoptosis via Bcl-2 inactivation in chemoresistant melanoma cells","volume":"6","author":"Doudican","year":"2008","journal-title":"Mol Cancer Res"},{"key":"10.4158\/EP10390.CR_bb0070","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1200\/JCO.2002.20.4.941","article-title":"Adrenocortical carcinoma: Clinical, morphologic, and molecular characterization","volume":"20","author":"Stojadinovic","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.4158\/EP10390.CR_bb0075","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/ijc.24104","article-title":"Methionine depletion with recombinant methioninase: In vitro and in vivo efficacy against neuroblastoma and its synergism with chemotherapeutic drugs","volume":"124","author":"Hu","year":"2009","journal-title":"Int J Cancer"},{"key":"10.4158\/EP10390.CR_bb0080","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1017\/S0031182005009108","article-title":"Immunomodulatory effect of various anti-parasitics: A review","volume":"132","author":"Sajid","year":"2006","journal-title":"Parasitology"},{"key":"10.4158\/EP10390.CR_bb0085","first-page":"636","article-title":"Thiabendazole: A potential adjuvant in cancer therapy","volume":"80","author":"Lundy","year":"1976","journal-title":"Surgery"},{"key":"10.4158\/EP10390.CR_bb0090","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0304-3835(01)00382-2","article-title":"In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by albendazole","volume":"165","author":"Pourgholami","year":"2001","journal-title":"Cancer Lett"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20404434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20404434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/E471V4567W504858.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:53:49Z","timestamp":1761515629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20404434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S1530891X20404434"],"URL":"https:\/\/doi.org\/10.4158\/ep10390.cr","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mebendazole Monotherapy and Long-Term Disease Control in Metastatic Adrenocortical Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP10390.CR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}